Pharmaceutical News and Articles

FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced ne

Local Outbreaks Can Motivate The Vaccine-Hesitant, Poll Finds

COVID-19 and influenza burned through the U.S. during this year s cold and flu season, and deadly measles outbreaks have sickened people in 19 states. So what d

Surgery Not Necessary In Some Early-Stage Breast Cancers, Study Says

Surgery might not be needed to treat as many as 60 of early-stage breast cancers, a new study says. Breast cancers that have been completely wiped out by chemot

Breasts Can Shrink Following Cancer Surgery, Radiation

Breast-conserving therapy for breast cancer might not conserve as much as previously thought, a new study suggests. Women s breasts can shrink considerably afte

More Type 1 Diabetics Are Obese, Taking GLP-1 Drugs

Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among expe

Bad Sleep Linked To Alzheimer's-Related Brain Changes

Certain stages of sleep deep sleep and dream sleep appear to contribute to brain health in ways that affect risk of Alzheimer s disease, a new study says. Peopl

Smartwatches Can Help People Control Diabetes Through Exercise

it could be a powerful tool for helping people with type 2 diabetes stay active, a new study says. Participants were more likely to start and maintain an exerci

Monthly News Roundup - March 2025

FDA Approves Tremfya for Adults Patients with Active Crohn s Disease In March, Johnson Johnson announced the U.S. Food and Drug Administration (FDA) approval of

FDA Issues Complete Response Letter for Etripamil for PSVT

FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A or B With or Without Inhibitors